Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Toltrazuril Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102731351B reveals a phosgene-free route for toltrazuril intermediates, offering safer manufacturing and cost reduction in veterinary chemical production.
Novel synthesis of 4-trifluoromethylsulfanyl aniline via anhydrous HF fluorination. Cost-effective route for green veterinary drug intermediates with high purity.